Dianthus Therapeutics (DNTH) EBT Margin (2022 - 2025)
Historic EBT Margin for Dianthus Therapeutics (DNTH) over the last 4 years, with Q3 2025 value amounting to 9250.0%.
- Dianthus Therapeutics' EBT Margin fell 80780400.0% to 9250.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 4076.22%, marking a year-over-year decrease of 28187700.0%. This contributed to the annual value of 1355.24% for FY2024, which is 1808600.0% up from last year.
- Per Dianthus Therapeutics' latest filing, its EBT Margin stood at 9250.0% for Q3 2025, which was down 80780400.0% from 16333.68% recorded in Q2 2025.
- Dianthus Therapeutics' EBT Margin's 5-year high stood at 668.2% during Q3 2022, with a 5-year trough of 16333.68% in Q2 2025.
- In the last 4 years, Dianthus Therapeutics' EBT Margin had a median value of 1558.58% in 2024 and averaged 3230.48%.
- Its EBT Margin has fluctuated over the past 5 years, first soared by 4224100bps in 2024, then crashed by -153945500bps in 2025.
- Dianthus Therapeutics' EBT Margin (Quarter) stood at 855.57% in 2022, then crashed by -188bps to 2467.61% in 2023, then grew by 15bps to 2106.03% in 2024, then plummeted by -339bps to 9250.0% in 2025.
- Its EBT Margin was 9250.0% in Q3 2025, compared to 16333.68% in Q2 2025 and 2526.74% in Q1 2025.